Patents directed to polymorphs of pharmaceutical compounds can be of significant commercial importance. However, care needs to be taken both during drafting and prosecution to increase the chance of success at the European Patent Office. This webinar will discuss some of the issues faced for patent applications for polymorphs and how those issues can be addressed at the EPO, as well as looking at some recent case law.

Topics will include:

Neurodegenerative disorders affect the structure and function of the central nervous system, leading to the progressive loss of cognitive, motor, and sensory abilities. They include Alzheimer's disease, Parkinson’s disease, motor neuron disease, multiple sclerosis, Huntington’s disease, stroke and traumatic brain injury.

The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe.

Join us for an insightful workshop on the art of delegation. This learned skill is the key to unlocking increased productivity as well as personal growth for leaders, senior managers and entrepreneurs. This interactive, informal session is designed to help you master skills that will lead to effective leadership and build trust within your team, empowering others to take ownership. Practical tips will help you prioritise tasks, improve time management, foster collaboration and elevate your leadership potential with smart delegation gaining the headspace you need to move forward.

FDA Regulatory Roadmap - Drop-in Clinic offers UK and European life sciences and medical device companies personalised, 1-on-1 consultations with FDA specialist Mark Swanson. The 20-30 minute sessions will provide tailored guidance on navigating U.S. FDA regulations.

US Market-Entry Masterclass - FDA Regulatory Roadmap is an online masterclass aimed at medical device and life science product companies seeking to expand into the U.S. market. This 90-minute session, organised by GTM Global in association with QRx Partners, will provide crucial guidance on navigating the complex U.S. regulatory landscape, especially FDA requirements.